Clearline Capital LP Amryt Pharma PLC Transaction History

Clearline Capital LP

  • $2.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$7.0 - $14.77 $12,376 - $26,113
-1,768 Reduced 0.28%
630,174 $9.19 Million
Q1 2022

May 16, 2022
BUY
$6.3 - $10.86 $199,999 - $344,761
31,746 Added 5.29%
631,942 $5.23 Million
Q4 2021

Feb 14, 2022
BUY
$9.44 - $12.24 $893,968 - $1.16 Million
94,700 Added 18.73%
600,196 $6.48 Million
Q3 2021

Nov 15, 2021
BUY
$9.63 - $12.47 $4.87 Million - $6.3 Million
505,496 New
505,496 $6.09 Million

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Clearline Capital LP Portfolio

Follow Clearline Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Clearline Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email